Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$82.56 - $93.49 $82 - $93
1 New
1 $0
Q2 2021

Aug 16, 2021

SELL
$51.81 - $118.56 $414 - $948
-8 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$111.01 - $139.48 $38,076 - $47,841
-343 Reduced 97.72%
8 $1,000
Q3 2020

Nov 13, 2020

BUY
$75.65 - $93.58 $75 - $93
1 Added 0.29%
351 $31,000
Q2 2020

Aug 11, 2020

BUY
$84.96 - $118.91 $29,056 - $40,667
342 Added 4275.0%
350 $31,000
Q1 2020

May 12, 2020

SELL
$74.34 - $121.82 $446 - $730
-6 Reduced 42.86%
8 $1,000
Q3 2019

Nov 13, 2019

SELL
$117.16 - $138.52 $2,811 - $3,324
-24 Reduced 63.16%
14 $2,000
Q2 2019

Aug 14, 2019

BUY
$81.74 - $120.34 $899 - $1,323
11 Added 40.74%
38 $5,000
Q1 2019

May 14, 2019

SELL
$83.25 - $102.12 $249 - $306
-3 Reduced 10.0%
27 $2,000
Q4 2018

Feb 13, 2019

SELL
$90.66 - $116.63 $1,722 - $2,215
-19 Reduced 38.78%
30 $3,000
Q3 2018

Nov 13, 2018

SELL
$89.96 - $114.58 $629 - $802
-7 Reduced 12.5%
49 $6,000
Q2 2018

Aug 01, 2018

SELL
$71.53 - $95.75 $143 - $191
-2 Reduced 3.45%
56 $5,000
Q1 2018

May 16, 2018

SELL
$60.72 - $74.41 $1,518 - $1,860
-25 Reduced 30.12%
58 $4,000
Q4 2017

Feb 13, 2018

BUY
$44.96 - $58.99 $3,731 - $4,896
83
83 $5,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.21B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.